Advertisement

Topics

Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPR

11:37 EDT 10 May 2017 | Labiotech.eu

Synbio startup Oxford Genetics has licensed CRISPR from Emmanuelle Charpentier’s company, ERS Genomics, to boost its platform. Synthetic biology has so far remained on the fringe of biotech, but one company, Oxford Genetics, is demonstrating its use in therapeutics. To ...

This awesome article Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPR appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPR

NEXT ARTICLE

More From BioPortfolio on "Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPR"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...